Faculty Sponsor

Jana Stedman

College

Nursing

Department/Program

Valparaiso University Physician Assistant Program

Presentation Type

Poster Presentation

Symposium Date

Summer 7-24-2024

Abstract

Objectives: Given the rising prevalence of obesity and the growing demand for bariatric interventions, it is essential to provide evidence-based comparisons of the two most common procedures, Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) and Laparoscopic Sleeve Gastrectomy (LSG). This research essay aims to examine the difference in excess weight loss and type 2 diabetes mellitus (T2DM) resolution outcomes between the procedures, empowering patients to make informed medical decisions about which surgical technique they would prefer. In evaluating these outcomes and educating patients about them, individuals can align their post-op goal with the most suitable bariatric surgical intervention. Methods: Valpo summon and Google Scholar were searched for English language meta-analysis and randomized controlled trials (RCTs) comparing roux-en-Y gastric bypass and sleeve gastrectomy published from 2018-2024. Results: Five studies were included in the final analysis, 3 meta-analysis and 2 RCTs. Overall, results revealed no significant differences between LRYGB and LSG in terms of excess weight loss and T2DM resolution. Conclusion: There is no significant difference between LRYGB and LSG in terms of T2DM resolution and excess weight loss. Some study’s findings suggest that LRYGB yields greater excess weight loss with statistical significance, but the actual difference is not great enough to be clinically relevant for patients choosing which surgery to undergo.

Keywords: Roux-en-Y gastric bypass, sleeve gastrectomy, weight loss, type 2 diabetes mellitus

Biographical Information about Author(s)

Cara Rodriguez has a special interest in the management of chronic conditions and plans on working in Primary Care in Chicago following graduation. Cara will be presenting on Sleeve Gastrectomy Versus Gastric Bypass and their outcomes in regard to Weight Loss & Type 2 Diabetes.

Share

COinS